Close
Close
ALK mutation related non-small cell lung cancer
9959 views
2.54545454545
2.5 from 11 votes

 

Prof Demetri describes two key presentations from ASCO 2010: the rapid progress made developing a therapy for ALK mutation related non-small cell lung cancer patients and the encouraging results of a phase I study into inflammatory myofibroblastic tumour patients with the ALK mutation. Prof Demitri goes on to discuss his current research into the Hsp90 pathway, kinase inhibitors, cancer profiling and IGF-1 receptor agonists.

2.54545454545
2.5 from 11 votes
Free Newsletter
Find a Clinical Trial
Trending videos
by Abidemi Uruejoma
29,263 views
by Christine DuBois
23,808 views
by Abidemi Uruejoma
21,632 views
News Articles